KUALA LUMPUR: Covid-19 patients who took Ivermectin were more likely to get diarrhoea, says Datuk Dr Noor Azmi Ghazali.
The Deputy Health Minister I said the ministry's clinical trials concluded that other than giving patients an upset stomach, there were no significant differences between those given Ivermectin and those treated using Covid-19 standard care treatment.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
Related stories:
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Thank you for your report!
